Indicia Revenue and Competitors
Estimated Revenue & Valuation
- Indicia's estimated annual revenue is currently $6M per year.
- Indicia's estimated revenue per employee is $201,000
Employee Data
- Indicia has 30 Employees.
- Indicia grew their employee count by -3% last year.
Indicia Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Indicia?
Au cœur de notre métier : la stérilité Entreprise française au sein du groupe Protex International, notre savoir-faire historique est la fabrication de produits liquides stériles. Partenaire de confiance des industriels de la Pharma, du Diagnostic, de la Cosmétique et des Biotechs, Indicia propose des prestations de production industrielle aux entreprises souhaitant externaliser la formulation, la stérilisation et le conditionnement de réactifs liquides ou semi-liquides. Cette expertise inclut en particulier la production en sous-traitance de milieux de culture pour la Microbiologie. Forte de cette expertise, Indicia commercialise sa propre gamme de milieux pour les contrôles microbiologiques traditionnels (bouillons, géloses) et propose une solution innovante pour la microbiologie rapide par cytométrie en flux (METIS) pour les industries cosmétiques et agro-alimentaires.
keywords:N/A
N/A
Total Funding
30
Number of Employees
$6M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Indicia News
Polícia indicia e pede prisão preventiva de Saul Klein por crimes sexuais. Outras nove pessoas também tiveram detenção solicitada;...
Law enforcement also seized indicia of drug distribution, including drug packaging, a digital scale, and nearly $1,700 in cash.
... You!Extension Of Fox Factory Complicates Reliance On Indicia Of Non-Obviousness. 14 April 2022. by Jeremy R. Kriegel. Marshall, Gerstein & Borun LLP.